⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for daunorubicin hydrochloride

Every month we try and update this database with for daunorubicin hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous LeukemiaNCT00002549
Leukemia
filgrastim
busulfan
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
idarubicin
mesna
mitoxantrone hy...
allogeneic bone...
autologous bone...
peripheral bloo...
radiation thera...
15 Years - 60 YearsNational Cancer Institute (NCI)
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic LeukemiaNCT00002785
Leukemia
filgrastim
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
mesna
methotrexate
methylprednisol...
pegaspargase
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
low-LET cobalt-...
low-LET photon ...
- 1 YearChildren's Oncology Group
Doxorubicin in Treating Patients With AIDS-Related Kaposi's SarcomaNCT00002985
Sarcoma
daunorubicin hy...
pegylated lipos...
- Roswell Park Cancer Institute
Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT01238211
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Core Binding Fa...
Secondary Acute...
Therapy-Related...
Cytarabine
Dasatinib
Daunorubicin Hy...
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid LeukemiaNCT00004128
Leukemia
aldesleukin
filgrastim
busulfan
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
autologous bone...
peripheral bloo...
radiation thera...
15 Years - 60 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaNCT00408005
T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsNational Cancer Institute (NCI)
6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT02472626
Untreated Adult...
6,8-Bis(benzylt...
Cytarabine
Daunorubicin Hy...
60 Years - Wake Forest University Health Sciences
Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaNCT00039117
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Secondary Acute...
Untreated Adult...
oblimersen sodi...
cytarabine
daunorubicin hy...
laboratory biom...
pharmacological...
60 Years - National Cancer Institute (NCI)
Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic LymphomaNCT00275106
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisolone
thioguanine
vincristine sul...
radiation thera...
- 21 YearsNational Cancer Institute (NCI)
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00002756
Leukemia
filgrastim
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
mercaptopurine
methotrexate
prednisone
therapeutic hyd...
vincristine sul...
- 1 YearChildren's Oncology Group
Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNCT01627041
Acute Myeloid L...
Adult Acute Bas...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Alkylating Agen...
Secondary Acute...
Cytarabine
Daunorubicin Hy...
Decitabine
Laboratory Biom...
Pharmacological...
18 Years - 65 YearsNational Cancer Institute (NCI)
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid LeukemiaNCT03900949
Acute Myeloid L...
Allogeneic Hema...
Cytarabine
Daunorubicin Hy...
Gemtuzumab Ozog...
Midostaurin
18 Years - Ohio State University Comprehensive Cancer Center
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00002744
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 YearsChildren's Oncology Group
S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaNCT00066794
Leukemia
filgrastim
sargramostim
cyclosporine
cytarabine
daunorubicin hy...
56 Years - SWOG Cancer Research Network
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00004217
Leukemia
filgrastim
sargramostim
cytarabine
daunorubicin hy...
valspodar
56 Years - SWOG Cancer Research Network
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid LeukemiaNCT03900949
Acute Myeloid L...
Allogeneic Hema...
Cytarabine
Daunorubicin Hy...
Gemtuzumab Ozog...
Midostaurin
18 Years - Ohio State University Comprehensive Cancer Center
Different Therapies in Treating Infants With Newly Diagnosed Acute LeukemiaNCT00550992
Leukemia
anti-thymocyte ...
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
melphalan
mercaptopurine
methotrexate
mitoxantrone hy...
pegaspargase
prednisolone
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
allogeneic bone...
allogeneic hema...
umbilical cord ...
- 1 YearDutch Childhood Oncology Group
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT01256398
Acute Lymphobla...
Adult B Acute L...
Alemtuzumab
Allogeneic Hema...
Autologous Hema...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide Phosp...
Filgrastim
Fludarabine Pho...
In Vitro-Treate...
Laboratory Biom...
Leucovorin Calc...
Melphalan
Mercaptopurine
Methotrexate
Pegfilgrastim
Pharmacological...
Tacrolimus
Vincristine Sul...
18 Years - National Cancer Institute (NCI)
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaNCT00002704
Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 YearsNational Cancer Institute (NCI)
Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00124644
Leukemia
cytarabine
daunorubicin hy...
etoposide
tipifarnib
chemotherapy
enzyme inhibito...
high-dose chemo...
18 Years - 59 YearsNational Cancer Institute (NCI)
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid LeukemiaNCT00004215
Anemia
Leukemia
Neutropenia
Thrombocytopeni...
filgrastim
leridistim
cytarabine
daunorubicin hy...
55 Years - Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsNCT02883049
B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 YearsNational Cancer Institute (NCI)
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaNCT00002704
Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 YearsNational Cancer Institute (NCI)
Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT01349972
Acute Myeloid L...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
alvocidib
daunorubicin hy...
mitoxantrone hy...
cytarabine
18 Years - 70 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic LeukemiaNCT00002532
Leukemia
filgrastim
asparaginase
cytarabine
daunorubicin hy...
dexamethasone
etoposide
idarubicin
ifosfamide
leucovorin calc...
methotrexate
prednisolone
vindesine
15 Years - 65 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaNCT00408005
T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00002744
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 YearsChildren's Oncology Group
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaNCT00742625
Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Untreated Adult...
daunorubicin hy...
cytarabine
bortezomib
60 Years - 75 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's LymphomaNCT00002471
Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
methotrexate
methylprednisol...
therapeutic hyd...
thiotepa
vincristine sul...
- Memorial Sloan Kettering Cancer Center
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaNCT00742625
Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Untreated Adult...
daunorubicin hy...
cytarabine
bortezomib
60 Years - 75 YearsNational Cancer Institute (NCI)
Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid LeukemiaNCT00268229
Leukemia
cytarabine
daunorubicin hy...
imatinib mesyla...
18 Years - The Cleveland Clinic
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesNCT00454480
Leukemia
Myelodysplastic...
alemtuzumab
arsenic trioxid...
azacitidine
busulfan
clofarabine
cytarabine
daunorubicin hy...
fludarabine pho...
gemtuzumab ozog...
melphalan
tipifarnib
DNA methylation...
cytogenetic ana...
gene expression...
mutation analys...
diagnostic labo...
immunologic tec...
allogeneic hema...
nonmyeloablativ...
- National Cancer Institute (NCI)
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous LeukemiaNCT00002549
Leukemia
filgrastim
busulfan
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
idarubicin
mesna
mitoxantrone hy...
allogeneic bone...
autologous bone...
peripheral bloo...
radiation thera...
15 Years - 60 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaNCT00005603
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
1 Year - 21 YearsChildren's Oncology Group
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid LeukemiaNCT05955261
Acute Myeloid L...
Venetoclax
Azacitidine
Cytarabine
Gemtuzumab Ozog...
Daunorubicin Hy...
Fludarabine Pho...
Idarubicin Hydr...
Mitoxantrone Hy...
Etoposide
Gilteritinib
29 Days - 21 YearsSt. Jude Children's Research Hospital
Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT02971397
Acute Myeloid L...
Bone Marrow Asp...
Cytarabine
Daunorubicin Hy...
Laboratory Biom...
18 Years - Wake Forest University Health Sciences
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsNCT02883049
B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 YearsNational Cancer Institute (NCI)
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down SyndromeNCT02521493
Acute Myeloid L...
Down Syndrome
Myelodysplastic...
Myeloid Leukemi...
Myeloproliferat...
Asparaginase
Asparaginase Er...
Cytarabine
Daunorubicin Hy...
Etoposide
Laboratory Biom...
Mitoxantrone Hy...
Thioguanine
91 Days - 3 YearsChildren's Oncology Group
Combination Chemotherapy in Treating Adults With Acute Lymphocytic LeukemiaNCT00002531
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
etoposide
ifosfamide
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
teniposide
thioguanine
vincristine sul...
vindesine
allogeneic bone...
peripheral bloo...
radiation thera...
15 Years - 65 YearsNational Cancer Institute (NCI)
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaNCT00003436
Leukemia
Myelodysplastic...
amsacrine
asparaginase
cytarabine
daunorubicin hy...
etoposide
methotrexate
mitoxantrone hy...
therapeutic hyd...
allogeneic bone...
- 15 YearsNational Cancer Institute (NCI)
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic LeukemiaNCT00022737
Childhood Acute...
Recurrent Child...
filgrastim
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
etoposide
ifosfamide
imatinib mesyla...
leucovorin calc...
mercaptopurine ...
methotrexate
pegaspargase
vincristine sul...
allogeneic bone...
peripheral bloo...
umbilical cord ...
radiation thera...
1 Year - 21 YearsNational Cancer Institute (NCI)
Doxorubicin in Treating Patients With AIDS-Related Kaposi's SarcomaNCT00002985
Sarcoma
daunorubicin hy...
pegylated lipos...
- Roswell Park Cancer Institute
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaNCT02003222
Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 YearsNational Cancer Institute (NCI)
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00557193
Acute Lymphobla...
Acute Undiffere...
Childhood T Acu...
Asparaginase
Biospecimen Col...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Echocardiograph...
Etoposide
Filgrastim
Laboratory Biom...
Lestaurtinib
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Multigated Acqu...
Pegaspargase
Pharmacological...
Prednisone
Therapeutic Hyd...
Vincristine Sul...
- 1 YearChildren's Oncology Group
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia PatientsNCT02835222
Untreated Adult...
Cytarabine
Daunorubicin Hy...
Selinexor
18 Years - Wake Forest University Health Sciences
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesNCT00096135
Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 YearsChildren's Oncology Group
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia PatientsNCT02835222
Untreated Adult...
Cytarabine
Daunorubicin Hy...
Selinexor
18 Years - Wake Forest University Health Sciences
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic LymphomaNCT00004228
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 30 YearsChildren's Oncology Group
PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00093600
Acute Myeloid L...
cytarabine
daunorubicin hy...
midostaurin
18 Years - 60 YearsNovartis
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid LeukemiaNCT04214249
Acute Myeloid L...
Acute Myeloid L...
Acute Myeloid L...
Secondary Acute...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Computed Tomogr...
Cytarabine
Daunorubicin Hy...
Echocardiograph...
Hematopoietic C...
Idarubicin Hydr...
Multigated Acqu...
Pembrolizumab
Punch Biopsy
18 Years - 75 YearsNational Cancer Institute (NCI)
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid LeukemiaNCT00002658
Leukemia
Neutropenia
filgrastim
amsacrine
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
idarubicin
mitoxantrone hy...
thioguanine
tretinoin
allogeneic bone...
autologous bone...
peripheral bloo...
radiation thera...
15 Years - National Cancer Institute (NCI)
Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 MutationsNCT02323607
Recurrent Adult...
Secondary Acute...
Therapy-Related...
Untreated Adult...
Pacritinib
Cytarabine
Daunorubicin Hy...
Decitabine
Laboratory Biom...
Pharmacological...
18 Years - Ohio State University Comprehensive Cancer Center
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeNCT00002798
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Secondary Myelo...
Untreated Child...
asparaginase
daunorubicin hy...
fludarabine pho...
therapeutic hyd...
allogeneic bone...
3-dimensional c...
filgrastim
cytarabine
idarubicin
dexamethasone
thioguanine
etoposide
methotrexate
cyclophosphamid...
aldesleukin
busulfan
- 21 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Acute Lymphocytic LeukemiaNCT00002812
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
idarubicin
mercaptopurine
methotrexate
pegaspargase
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 21 YearsChildren's Oncology Group
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNCT00061945
Acute Undiffere...
B-cell Adult Ac...
B-cell Childhoo...
L1 Adult Acute ...
L1 Childhood Ac...
L2 Adult Acute ...
L2 Childhood Ac...
Philadelphia Ch...
Philadelphia Ch...
Philadelphia Ch...
T-cell Adult Ac...
T-cell Childhoo...
Untreated Adult...
Untreated Child...
allopurinol
cyclophosphamid...
daunorubicin hy...
vincristine sul...
dexamethasone
asparaginase
filgrastim
imatinib mesyla...
methotrexate
cytarabine
trimethoprim-su...
mercaptopurine
leucovorin calc...
alemtuzumab
acyclovir
laboratory biom...
pharmacological...
15 Years - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaNCT00022126
Leukemia
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
thioguanine
vincristine sul...
allogeneic bone...
radiation thera...
- 1 YearChildren's Oncology Group
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaNCT00006363
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaNCT00003671
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
leucovorin calc...
mercaptopurine
methotrexate
thioguanine
vincristine sul...
- 18 YearsChildren's Oncology Group
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene RearrangementNCT02828358
Acute Leukemia ...
B Acute Lymphob...
Mixed Phenotype...
Azacitidine
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Hydrocortisone ...
Laboratory Biom...
Leucovorin
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Pharmacological...
Prednisolone
Thioguanine
Vincristine
Vincristine Sul...
- 364 DaysNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Acute Promyelocytic LeukemiaNCT00276601
Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combination Chemotherapy in Treating Patients With Acute Promyelocytic LeukemiaNCT00276601
Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaNCT02003222
Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 YearsNational Cancer Institute (NCI)
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00814164
Leukemia
clofarabine
daunorubicin hy...
cytogenetic ana...
protein express...
immunologic tec...
pharmacological...
60 Years - 120 YearsRoswell Park Cancer Institute
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesNCT00096135
Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 YearsChildren's Oncology Group
Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaNCT00003934
Adult Acute Mye...
Adult Acute Pro...
Childhood Acute...
Untreated Adult...
Untreated Child...
tretinoin
daunorubicin hy...
cytarabine
mercaptopurine
methotrexate
arsenic trioxid...
- National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's LymphomaNCT00018954
Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
doxorubicin hyd...
etoposide
ifosfamide
mercaptopurine
methotrexate
prednisone
vincristine sul...
conventional su...
radiation thera...
- National Institutes of Health Clinical Center (CC)
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic LeukemiaNCT00002700
Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
autologous bone...
radiation thera...
15 Years - 60 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaNCT00075725
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaNCT03150693
B Acute Lymphob...
Allopurinol
Cytarabine
Daunorubicin Hy...
Vincristine Sul...
Dexamethasone
Pegylated L-Asp...
Methotrexate
Bone Marrow Asp...
Cyclophosphamid...
Mercaptopurine
Rituximab
Doxorubicin
Thioguanine
Inotuzumab Ozog...
Laboratory Biom...
18 Years - 39 YearsAlliance for Clinical Trials in Oncology
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaNCT00004056
Leukemia
filgrastim
asparaginase
cytarabine
daunorubicin hy...
melphalan
thioguanine
peripheral bloo...
- 21 YearsChildren's Oncology Group
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00720109
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Asparaginase
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide
Filgrastim
Hydrocortisone ...
Ifosfamide
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Pegaspargase
Prednisone
Radiation Thera...
Vincristine Sul...
2 Years - 30 YearsNational Cancer Institute (NCI)
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00814164
Leukemia
clofarabine
daunorubicin hy...
cytogenetic ana...
protein express...
immunologic tec...
pharmacological...
60 Years - 120 YearsRoswell Park Cancer Institute
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)NCT00866307
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Prophylactic Cr...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid LeukemiaNCT00416598
Acute Myeloid L...
Acute Myeloid L...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Untreated Adult...
Autologous Bone...
Autologous Hema...
Busulfan
Cytarabine
Daunorubicin Hy...
Decitabine
Etoposide
Filgrastim
Laboratory Biom...
Pharmacological...
15 Years - 59 YearsNational Cancer Institute (NCI)
Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification TherapyNCT00070174
Leukemia
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
methotrexate
mitoxantrone hy...
allogeneic bone...
- Children's Oncology Group
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNCT00003700
Leukemia
G-CSF
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
vincristine sul...
Allopurinol
15 Years - Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's LymphomaNCT00002691
Lymphoma
filgrastim
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mesna
methotrexate
vincristine sul...
- 21 YearsMemorial Sloan Kettering Cancer Center
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaNCT00075725
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00372593
Leukemia
asparaginase
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
mitoxantrone hy...
- 29 YearsChildren's Oncology Group
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaNCT00003436
Leukemia
Myelodysplastic...
amsacrine
asparaginase
cytarabine
daunorubicin hy...
etoposide
methotrexate
mitoxantrone hy...
therapeutic hyd...
allogeneic bone...
- 15 YearsNational Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: